Skip to content
hcg-service-hero-1

Insights From Halloran

Elizabeth BodiDec 4, 2024 1:00:00 PM< 1 min read

On-Demand: Inspection Readiness A Failure to Plan is a Plan to Fail

ON-DEMAND WEBINAR
Start Reading
Michelle PeterNov 29, 2024 11:16:51 AM< 1 min read

Best Content 2024: Managing a Trial Master File

2024 Best of Content
Start Reading
Sheila GwizdakNov 25, 2024 10:30:00 AM2 min read

Disrupting the Clinical Trial Ecosystem

Start Reading
Sheila GwizdakNov 20, 2024 5:57:18 PM3 min read

Moving Through Clinical Development and Operations Obstacles on the Path to Commercialization

Start Reading
Sheila GwizdakNov 14, 2024 11:24:31 AM4 min read

Key Takeaways from Halloran’s CORE Program: Advice for Clinical Leaders: Driving Quality, Innovation, and Engagement in Modern Clinical Trials

“I always walk away rejuvenated and inspired,” Malachi Bierstein, Chief Commercial ...
Start Reading
Halloran Consulting GroupOct 16, 2024 11:47:13 AM2 min read

ProductLife Group (PLG) Acquires Halloran Consulting Group

BOSTON; Oct. 16, 2024 (Business Wire) – ProductLife Group (PLG), a trusted global leader ...
Start Reading
Jillian FarrelOct 15, 2024 11:12:42 AM8 min read

Three Key Impacts in 2025: Fundraising, ICH E6(R3), and Policy

A Q&A featuring Tania Zieja, President of Halloran Consulting Group.
Start Reading
Lyn AgostinelliAug 21, 2024 12:45:00 PM2 min read

483 Issues to Sites – Indicators of Sponsor Oversight Effectiveness

A U.S. Food and Drug Administration (FDA) Form 483 is issued to a company’s management at ...
Start Reading
Shawn Roach, PhD, RACAug 8, 2024 1:45:00 PM1 min read

Clinical Development Considerations for Small Molecules and Recombinant Proteins

Navigating the complexities of Chemistry, Manufacturing, and Controls (CMC) within the ...
Start Reading
Hema BalasubramanianAug 2, 2024 11:30:00 AM7 min read

How, Why, and When to Apply for an Orphan Drug Application

This article is written by Hema Balasubramanian and Mamta Puri-Lechner. In the rapidly ...
Start Reading